Skip to content
Educational information only. Not medical advice. We sell nothing and take no affiliate money.

Red flags of scam peptide sellers

Most people meet peptides through a seller's website or a social media post. These are the warning signs that regulators and researchers keep finding, and what testing of real online purchases showed.

Last reviewed October 27, 2026

Why this matters

Peptides sold online as "research chemicals" sit outside the normal drug system. No one checks them before they ship. FDA says their quality is unknown and they may be harmful.[1] These patterns show up again and again in FDA warning letters, consumer protection guidance and published test purchases.

1. Health claims on a "research only" product

A product cannot be "not for human use" and also be sold for weight loss. FDA warned one seller whose vials said "research use only" while its website described uses in diabetes and obesity and its Facebook page promoted weight loss. FDA said those claims showed the products were meant as drugs for people.[2] Another seller used "not for human consumption" disclaimers but also sold syringes and bacteriostatic water next to the vials. FDA was not persuaded by the disclaimers.[3]

2. Dosing advice from the seller

FDA has warned companies that sold research labeled GLP-1 drugs straight to consumers with dosing instructions.[1] In one study of online semaglutide sellers, a vendor that called its vials research only also handed out injection instructions.[4] A seller is not your clinician. When it gives dosing tips, it is also contradicting its own label.

3. Crypto, payment apps or "friends and family" only

In the semaglutide study, four of six sellers offered cryptocurrency, and one gave a discount for paying that way. One seller told buyers to send PayPal as "friends and family," which the researchers saw as a way to hide what the payment was for.[4] The FTC says that when someone insists you pay only by crypto, wire transfer, a payment app or a gift card, it is likely a scam.[5][6]

4. No real address, license or prescription

FDA says a safe online pharmacy gives a physical U.S. address and phone number, has a licensed pharmacist, is licensed by a state board, and requires a prescription.[7] None of the online semaglutide sellers in the study required a prescription.[4] A research chemical shop is not a pharmacy at all. If you cannot find out who runs it or where it is, you have no one to hold responsible.

5. Copied, generic or mismatched CoAs

A real Certificate of Analysis belongs to one batch and should name the lab and the maker.[8] When FDA reviewed CoAs for BPC-157, most showed only a purity number, and the substance named did not always match the paperwork.[9] In the semaglutide study, documents claimed at least 99 percent purity, but testing found only about 8 to 14 percent.[4] Watch for the same CoA on every batch, no batch number, or no chromatogram. Our guide to reading a CoA covers this in detail.

6. Prices far below the real market

FDA lists prices that seem too good to be true as a warning sign of an unsafe online seller.[7][1] In the semaglutide study, researchers ordered from the cheapest, most visible sellers. Three of the six never delivered anything, and the authors called them scams.[4]

7. Fake reviews and bought hype

In 2024 the FTC finalized a rule that bans fake reviews, including ones written by AI for people who do not exist. It also bans paying for reviews that must be positive, hiding that a reviewer works for the company, suppressing bad reviews, and buying fake followers or views.[10] Be wary of pages full of five star reviews posted close together, glowing "before and after" stories, and influencers who never say they are paid.

8. Pressure to buy right now

The FTC says scammers want you to act before you have time to think, while honest businesses let you take your time.[5] Countdown timers, "last batch" warnings and claims that a ban is coming are all pressure tactics.

What a real test purchase found

A 2024 peer reviewed study searched the web for semaglutide sold without a prescription and bought from six sellers.[4]

  • Three sellers never shipped anything.[4]
  • The three vials that did arrive failed more than half of the packaging and labeling checks.[4]
  • No germs grew from the samples, but endotoxin, a fever causing bacterial residue, was measurable in all three.[4]
  • Measured purity was about 8 to 14 percent, compared with the 99 percent the paperwork claimed. The amount of semaglutide also did not match the label.[4]
  • The authors classed every product they received as substandard or falsified.[4]

If you already bought from a seller like this

If you have symptoms, talk to a doctor and bring the product with you. You can report side effects and product problems to FDA through its MedWatch program.[11]

Sources

  1. U.S. Food and Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. Updated October 1, 2026. FDA safety page
  2. U.S. Food and Drug Administration. Warning Letter to Summit Research Peptides, MARCS-CMS 695607. December 10, 2024. FDA warning letter
  3. U.S. Food and Drug Administration. Warning Letter to USApeptide.com, MARCS-CMS 696885. February 26, 2025. FDA warning letter
  4. Ashraf AR, Mackey TK, Vida RG, et al. Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study. J Med Internet Res. 2024;26:e65440. doi:10.2196/65440
  5. Federal Trade Commission, Consumer Advice. How To Avoid a Scam. Updated August 13, 2026. FTC consumer advice
  6. Federal Trade Commission, Consumer Alert. A way to spot scams: how someone asks you to pay. July 22, 2026. FTC consumer alert
  7. U.S. Food and Drug Administration, Consumer Updates. How to Buy Medicines Safely From an Online Pharmacy. Content current as of January 2, 2025. FDA consumer update
  8. U.S. Food and Drug Administration. Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients, Guidance for Industry (Revision 1). September 2016. FDA guidance (PDF)
  9. U.S. Food and Drug Administration. FDA Evaluation of BPC-157 Related Bulk Drug Substances. Briefing document, Pharmacy Compounding Advisory Committee meeting, July 23-24, 2026. FDA briefing document (PDF)
  10. Federal Trade Commission. Federal Trade Commission Announces Final Rule Banning Fake Reviews and Testimonials. Press release, August 14, 2024. FTC press release
  11. U.S. Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. July 26, 2024. FDA alert
Medical disclaimer

This page is educational information only. It is not medical advice and does not replace care from a licensed medical provider.

Scroll to Top